Table 5.
Method | All positive* | False positive* | All negative* | False negative* | False-positive rate | False-negative rate | Kappa value | Mean kappa | ||
---|---|---|---|---|---|---|---|---|---|---|
All grade 1 NSQIP complications | ||||||||||
DC Summary | 11 + | 2 + | 1- | 63 - | 3 - | 4 - | 2/66 (3.0%) | 7/18 (3.9%) | 0.646 | 0.717 |
Chart Review | 11 + | 2 + | 1 + | 63 - | 3 - | 4 + | 3/66 (4.5%) | 3/18 (16.7%) | 0.788 | |
Prospective | 11 + | 2 - | 1- | 63 - | 3 + | 4 + | NA | NA | NA | NA |
All grade 2 NSQIP complications | ||||||||||
DC Summary | 11 + | NA | 72 - | 1- | 0/72 (0%) | 1/12 (8.3%) | 0.950 | 0.975 | ||
Chart Review | 11 + | NA | 72 - | 1+ | 0/72 (0%) | 0/12 (0%) | 1.000 | |||
Prospective | 11 + | NA | 72 - | 1+ | NA | NA | NA | NA | ||
All grade 3 to 5 NSQIP complications | ||||||||||
DC Summary | 1+ | NA | 83 - | NA | 0/83 (0%) | 0/1 (0%) | 1 | 1 | ||
Chart Review | 1+ | NA | 83 - | NA | 0/83 (0%) | 0/1 (0%) | 1 | |||
Prospective | 1+ | NA | 83 - | NA | NA | NA | NA | NA |
Numbers indicate the number of patients with the particular pattern in those categories.